Last updated 2026-07-20
Portfolio
57
in our dataset
Rounds participated
63
Rounds led
0
Rounds' value
$35.9M
total disclosed, rounds participated
Stages
—
About
The 'Office of the Chief Scientist' (OCS) is a designation for several governmental units within various Israeli ministries, rather than a single startup or company. The most prominent historical OCS, which focused on industrial R&D, was established in 1965 and rebranded as the Israel Innovation Authority (IIA) in 2016. Other ministries, such as the Ministry of Innovation, Science and Technology, Ministry of Energy and Infrastructure, Ministry of Agriculture and Food Security, Ministry of Health, and Ministry of National Security, also have Chief Scientist offices that lead scientific activities and promote R&D in their respective fields.
Portfolio · 57
ZevaLed
Colored LED Lights
Trailze
Navigation SDK for Micromobility
CureFacts
Platform for Evidence-based Medicine
Castle Builders
Sharing Platform for Interactive Books and Media
O2Waterator
Water Pressure-based Aeration System for Fish Ponds
Leviticus Cardio
Wireless Solution for VAD Implants
Libra@Home
Portable Rehabilitation System for Balance Disorders
Inspecto
Early Detection of Food Contaminants
Amnis Therapeutics
Endovascular Technologies for Emergency Situations
Knil
Blockchain-based Content Discovery Platform
SolarBead
Smart Microinverter for Enhancing PV Yield
Salient Eye
SaaS-based Video Communication System
Roadcode
Pothole Repair
Amaizz Advanced Agriculture
Minimizing Postharvest Losses
Croosing
User Journey Management
Semorex Technologies
Cancer Therapeutics and IFI/SFI Diagnostics
Change Labs
Financial Health AI Platform
Curewize Health
Personalized Cancer Treatment
XACT Robotics
Image-guided Robotic Needle-steering System
Cyren
Cloud-based Cybersecurity
CMoo Systems
Smart Home and IoT Devices
Catalyst AgTech
Self-Destructing Pesticides
Etugo
Intelligent Home System
Wings&Rotors
Aerial Robotics
InvestieComp
Stock Market Prediction Signals for Traders
ParaSonic
Ultrasound Device for the Elimination of Lice
KeyPodOn
Wearable IoT Technology
Flywheel Energy
Flash Charger for Electrical Vehicles
Oplon Pure Science
Antimicrobial Coatings and Protective Products
FlowMed
Continuous Irrigation for Endoscopic Surgeries
PamBio
Antifibrinolytic Therapy for Acute Bleeding Conditions
Advanced Brine Solutions
Evaporation Technology for Brine and Industrial Wastewater
Koalys
Developer of an online audiology diagnosis platform designed to offer effective solutions for hearing impairment.
GlaucoPharm
Topically Treating Glaucoma
Renergy
Energy Recovery Technology for Desalination
Sonarax
Ultrasonic Connectivity and Communication Platform
Fanzone
Transportation Platform for Live Events
HeadSense
Noninvasive Multiparameter Brain Monitoring
FitFully
Virtual Fitting for Online Footwear Shopping
LapSpace Medical
Inflatable Balloon Retractor for Laparoscopic Procedures
Elloria Medical Technologies
Electro-chemical Hair Removal
Sesame Enable
Hands-free Accessibility for Mobile Devices
Weepo
Social Nightlife App
EXP Commerce
Ecommerce Buy-back Platform
JamStar
Guitar Teaching Application
Spondoolies
Cyptocurrency Mining Gear
Biologic
Biological Pest Control for Livestock
UniVerve
Micro-algae Biomass Production for Feedstock
B-Shoe Technologies
Fall Prevention with Smart Shoes
Ecofer
Automated Fertigation System
Pozzily Wireless Communication
Low-tier 4G base and Repeater Stations Developer
Genaphora
Pathogen Detection in Drinking and Source Water
Lesico CleanTech
Reducing the Volume of Liquid Waste in Water Treatment
LunGuard
Reflux Prevention Device for Ventilated and Tube-fed Patients
JetGuide
Real-time Monitoring for Dental Drilling and Neurosurgery
Mental Heal
Antipsychotic Treatment for Schizophrenia and Mood Disorders
IDD Therapeutics
Drug Discovery Platform for Cancer Treatments
Investment activity
6 portfolio exits on record.
Portfolio by sector
Health Tech & Life Sciences28
Industrial Technologies7
Cyber Security6
Agriculture & Food Technologies5
Undisclosed4
Energy Tech4
Business Software3
Automotive & Mobility Technologies2
Q&A
- What is the most recent exit for Office of the Chief Scientist?
- The most recent exit for Office of the Chief Scientist was the acquisition of BELKIN Vision by Alcon Pharmaceuticals in July 2024 for $81M.
- What is the primary sector focus for Office of the Chief Scientist's investments?
- Office of the Chief Scientist primarily focuses its investments in Health Tech & Life Sciences, with 28 portfolio companies in this sector.
- Can you name some notable portfolio companies in the Health Tech & Life Sciences sector?
- Notable portfolio companies in the Health Tech & Life Sciences sector include BELKIN Vision, which was acquired for $81M, and TytoCare, which has raised $203.6M.
- What is the typical investment stage for Office of the Chief Scientist?
- Office of the Chief Scientist predominantly invests in Seed stage companies, with 54 Seed rounds recorded.
- Which portfolio company has raised the most capital?
- TytoCare has raised the most capital among the portfolio companies, with $203.6M in its E round.
- Has Office of the Chief Scientist had any exits in the Cyber Security sector?
- Yes, Office of the Chief Scientist has had three exits in the Cyber Security sector, including the acquisition of Fieldbit in November 2021 and CyKick Labs in July 2018.
- What is the investment range for Office of the Chief Scientist?
- The investment range for Office of the Chief Scientist is between $160K and $8M.
- What was the acquisition value for BELKIN Vision?
- BELKIN Vision was acquired for $81M by Alcon Pharmaceuticals in July 2024.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
Identifiers & details
| Founded | 1965 |
|---|---|
| Wikidata QID | Q16128627 |
Radar intelligence
Wikidata
| QID | Q16128627 |
|---|